Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD)

Case Reports and Clinical Practice Review

Volumn 16, Issue 9, 2010, Pages 433-439

  Romanowska, Magdalena ^a   Banaszkiewicz, Aleksandra ^b   Nowak, Iwona ^a   Radzikowski, Andrzej ^b   Brydak, Lidia B ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Inflammatory bowel disease (IBD); Influenza; Vaccination

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CIPROFLOXACIN; HEMAGGLUTININ; INACTIVATED VACCINE; INFLIXIMAB; INFLUENZA VACCINE; METRONIDAZOLE; PREDNISONE; PROTEIN ANTIBODY; SIALIDASE; VIRUS ANTIGEN; 5 ACETAMIDOSALICYLIC ACID; ANTIINFLAMMATORY AGENT; IMMUNOMODULATING AGENT; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ADULT; ALLERGIC REACTION; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; EPIDEMIC; HEADACHE; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MALAISE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRESCHOOL CHILD; SHIVERING; ADOLESCENT; ANTIBODY TITER; FEMALE; INFECTION RESISTANCE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A; POLAND; SEASON; VIROLOGY;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; EPIDEMICS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, HUMORAL; IMMUNIZATION; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEURAMINIDASE; POLAND; SEASONS;

EID: 77956952673     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Collier L, Oxford J: Wirusologia (Human virology). Warsaw, PZWL, 2001
2. Nicholson KG, Webster RG, Hay AJ: Textbook of INFLUENZA. Oxford, Blackwell Science, 1998
3. Brydak LB: Grypa. Pandemia grypy - mit czy realne zagrożenie? (Influenza. Influenza pandemic - myth or real threat?) Warsaw, Oficyna Wydawnicza RYTM, 2008
4. Centers for Disease Control and Prevention. Prevention and Control of Seasonal Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2009; 56(No. RR-6): 1-53
5. Shiraishi K, Lindtrsom SE, Saito T et al: Genetic analysis of an influenza B virus isolated from a patient with encephalopathy in Japan. J Med Virol, 2001; 65(3): 590-597
6. Winesett M: Inflammatory bowel disease in children and adolescents. Pediatr Ann, 1997; 26: 227-234
7. Weersma RK, van Dullemen HM, van der Steege G et al: Review article: Inflammatory bowel disease and genetics. Aliment Pharmacol Ther, 2007; 26(Suppl.2): 57-65
8. Kangro HO, Chong SK, Hardiman A et al: A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology, 1990; 98(3): 549-553
9. Sands BE, Cuffari C, Katz J et al: Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis, 2004; 10(5): 677-692
10. Melmed GY, Ippoliti AF, Papadakis KA et al: Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol, 2006; 101(8): 1834-1840
11. Mamula P, Markowitz JE, Piccoli DA et al: Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenetrol Hepatol, 2007; 5(7): 851-856
12. Lu Y, Jacobson DL, Ashworth LA et al: Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol, 2009; 104(2): 444-453
13. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr, 2005; 41(1): 1-7
14. Centers for Disease Control and Prevention: WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza. The 2005-2006 WHO influenza reagent kit for identification of influenza isolates. Atlanta, 2005
15. Manuguerra J-C, Hannoun C: Influenza and other viral respiratory diseases. Surveillance and laboratory diagnosis. Paris, Institut Pasteur, 1999
16. Aymard-Henry M, Coleman MT, Dowdle WR et al: Influenza virus neuraminidase and neuraminidase inhibition test procedures. Bull WHO, 1973; 48: 199-202
17. Douglas AR: Assay of neuraminidase (NA) activity and neuraminidase inhibition test. Report of the WHO International Collaborative Center for Reference and Research on the Influenza Virus at Mill Hill. London: National Institute for Medical Research, 1993
18. Kroneman MW, van Essen GA, Tacken MAJB et al: Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine, 2004; 22(17-18):2163-2170
19. Chung EK, Casey R, Pinto-Martin JA et al: Routine and influenza vaccination rates in children with asthma. Ann Allergy Asthma Immunol, 1998; 80: 318-322
20. Nichol KL: Preventing influenza: the physician's role. Semin Respir Infect, 1992; 7(1): 71-77
21. Brydak LB, Rokicka-Milewska R, Machała M et al: Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr Infect Dis J, 1998; 17(2): 125-129
22. Brydak LB, Hryniewicz HJ, Machała M, Horban A: Humoral Response to influenza vaccination in HIV-infected patients. Clin Drug Invest, 1999; 17(6): 441-449
23. Brydak LB, Roszkowska-Blaim M, Machała M et al: Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine, 2000; 18(28): 3280-3286
24. Brydak LB, Rokicka-Milewska R, Machała M, Jackowska T: Studies on the humoral immune response to hemagglutinin of influenza vaccine in children with acute lymphoblastic leukemia after chemotherapy treatment. International Journal of Pediatric Hematology/Oncology, 2000; 7(1): 29-40
25. Rokicka-Milewska R, Brydak LB, Machała M, Klukowska A: Antibody response to influenza vaccine in children with severe and mild hemophila. International Journal of Pediatric Hematology/Oncology, 2000; 7(1): 21-27
26. Brydak LB, Guzy J, Starzyk J et al: Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer, 2001; 9(1): 65-68
27. Brydak LB, Roszkowska-Blaim M, Machała M et al: Immunological response to influenza vaccination in children with renal failure. Nephrol Dial Transplant, 2001; 16(3): 643-644
28. Marczyńska M, Brydak LB, Machała M et al: Influenza vaccination in HIV-infected children. Acta Paediatr, 2001; 90(1-2): 466-467
29. Brydak LB, Fracka B, Machała M, Szkudlarek D: Antibody response to influenza vaccine in children with bronchopulmonary dysplasia. Infection, 2001; 29(2): 181-182
30. Brydak LB, Machała M, Myśliwska J et al: Immune response to influenza vaccination in an elderly population. J Clin Immunol, 2003; 23(3): 214-222
31. Brydak LB, Machała M, Łaguna P, Rokicka-Milewska R: Antibody response to influenza vaccination in splenectomized patients in Poland. J Clin Immunol, 2004; 24(3): 225-236
32. Brydak LB, Machała M, Centkowski P et al: Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine, 2006; 24(44-46): 6620-6623
33. Zycinska K, Romanowska M, Nowak I et al: Antibody response to inactivated subunit influenza vaccine in patients with Wegeners granulomatosis. J Physiol Pharmacol, 2007; 58(Suppl.5): 819-828
34. Romanowska M, Rybicka K, Nowak I et al: Antibody response to influenza vaccination in patients suffering from asthma. J Physiol Pharmacol, 2007; 58(Suppl.5): 583-589
35. Centkowski P, Brydak L, Machala M et al: for the Polish Lymphoma Research Group. Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma. J Clin Immunol, 2007; 27(3): 339-346
36. Brydak LB, Romanowska M, Nowak I et al: Antibody response to influenza vaccine in coronary artery disease - a substudy of the FLUCAD study. Med Sci Monit, 2009; 15(7): PH85-PH91
37. Committee for Proprietary Medicinal Products (CPMP): Note for guidance on harmonisation of requirements for influenza vaccines (revision). Mar 12: CPMP/BWP/214/96, 1997
38. Ada GL: Immune response. In: Granoff A, Webster RG (eds.), Encyclopedia of virology. London, Academic Press, 1999; 812-818
39. Potter CW, Oxford JS: Determinants of immunity to influenza in man. Br Med Bull, 1979; 35: 69-75
40. Glathe H, Lange W: Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents. Drugs Aging, 1995; 6(5): 368-387
41. Powers DC, Kilbourne ED, Johansson BE: Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Clin Diagn Lab Immunol, 1996; 3(5): 511-516
42. Ada GL, Jones PD: The immune response to influenza infection. Curr Topics Microbiol Immunol, 1986; 128: 1-54
43. Couch RB, Kasel JA, Gerin JL et al: Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis, 1974; 129: 411-420
44. Kilbourne ED, Palese P, Schulman JL: Inhibition of viral neuraminidase as a new approach to the prevention of influenza. In: Pollard M (ed.), Perspectives in virology. New York, Academic Press, 1975; 99-113
45. Aymard M, Ferraris O, Gerentes L et al: Neuraminidase assays. Dev Biol (Basel), 2003; 115: 75-83